Heart Failure, Congestive Clinical Trial
Official title:
Evaluation of a Nurse Case Management Model for Chronic Heart Failure
Despite established clinical practice guidelines, wide variations exist in the care of chronic heart failure (CHF) patients in Veterans Health Administration. Previous randomized, controlled studies have suggested that a nurse case management model may improve the outcomes of care for patients with CHF. However, these studies involved selected groups of patients (i.e., those who agreed to participate in randomized trials) in selected settings (i.e., tertiary care facilities); so, the findings are not likely to be indicative of the true effectiveness of case management in a large population of CHF patients.
BACKGROUND / RATIONALE:
Despite established clinical practice guidelines, wide variations exist in the care of
chronic heart failure (CHF) patients in Veterans Health Administration. Previous randomized,
controlled studies have suggested that a nurse case management model may improve the
outcomes of care for patients with CHF. However, these studies involved selected groups of
patients (i.e., those who agreed to participate in randomized trials) in selected settings
(i.e., tertiary care facilities); so, the findings are not likely to be indicative of the
true effectiveness of case management in a large population of CHF patients.
OBJECTIVE(S):
This study will evaluate the impact of a nurse practitioner case management model compared
with usual care in patients with congestive heart failure (CHF). Outcomes include
health-related quality of life, patient satisfaction, compliance with medication guidelines,
mortality, readmissions, bed days of care, outpatient visits, emergency room visits, and
pharmacy costs.
METHODS:
Patients with CHF will be identified by review of admission/discharge logs, review of clinic
schedules, and referrals from medical personnel. All patients in the northern half of VISN
11 (Ann Arbor, Detroit, Saginaw, and Battle Creek) will participate in a case management
program, in which they will receive care from nurse practitioners who will be supported by
practice guidelines, treatment algorithms, and guidance from cardiologists at the VA Ann
Arbor Health Care System. Patients in the southern half of the VISN (Indianapolis and
Danville) will make up the comparison group and will receive usual care for CHF patients.
All study participants will complete baseline and one and two year follow-up questionnaires
on health related quality of life, including the SF-36V and the Minnesota Living With Heart
Failure Questionnaire. Patient satisfaction will be assessed using the VA National
Ambulatory Care Survey. Additional data on the use of health care resources over the two
years following each patient�s index hospitalization will be collected from the Patient
Treatment File (PTF) and the Outpatient Census (OPC) File. Data on compliance with
medication guidelines will be obtained from the VISN 11 pharmacy database. Multivariate
analyses will be used, with the main study outcomes as dependent variables and intervention
vs. comparison group membership as independent variables, controlling for baseline
differences between intervention and comparison groups. Additional analyses will compare the
study outcomes for patients served by primary versus tertiary sites.
Semi-structured interviews will be conducted with participating providers at the beginning,
middle, and end of the study, to determine satisfaction with the program, as well as
specific components that were perceived to help or hinder its effectiveness.
STATUS:
All two-year follow-up questionnaires have been received and entered. Medical record
abstraction, which includes data on severity of disease, will continue through Dec 2007. All
interviews with medical center staff have been conducted, transcribed, and coded. We are in
the process of pulling one-year prior and one and two-year post data on comorbidities and
resource utilization. Analysis of survey, medical record, interview, and secondary data will
continue through spring of 2008, when the final report will be written.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |